Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-120893
Filing Date
2016-05-13
Accepted
2016-05-13 16:18:43
Documents
62
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-7427_110q.htm 10-Q 563874
2 EX-31.1 a16-7427_1ex31d1.htm EX-31.1 11167
3 EX-31.2 a16-7427_1ex31d2.htm EX-31.2 11096
4 EX-32.1 a16-7427_1ex32d1.htm EX-32.1 7503
  Complete submission text file 0001104659-16-120893.txt   3557364

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT avxs-20160331.xml EX-101.INS 580677
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avxs-20160331.xsd EX-101.SCH 44985
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avxs-20160331_cal.xml EX-101.CAL 39773
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT avxs-20160331_lab.xml EX-101.LAB 368573
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avxs-20160331_pre.xml EX-101.PRE 319762
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avxs-20160331_def.xml EX-101.DEF 220045
Mailing Address 2275 HALF DAY ROAD SUITE 160 BANNOCKBURN IL 60015
Business Address 2275 HALF DAY ROAD SUITE 160 BANNOCKBURN IL 60015 972-725-7797
AveXis, Inc. (Filer) CIK: 0001652923 (see all company filings)

EIN.: 901038273 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37693 | Film No.: 161648646
SIC: 2836 Biological Products, (No Diagnostic Substances)